Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Jonasch

Showing results (71-80 of 271) with videos related to

Pageof 28
Sort By:
European Radiology|November 13, 2015
The radiogenomic risk score stratifies outcomes in a renal cell cancer phase 2 clinical trialNeema Jamshidi, Eric Jonasch, Matthew Zapala, et al.
Clinical Genitourinary Cancer|December 16, 2014
First-Line and Sequential Use of Pazopanib Followed by Mammalian Target of Rapamycin Inhibitor Therapy Among Patients With Advanced Renal Cell Carcinoma in a US Community Oncology SettingNicholas J Vogelzang, Michelle D Hackshaw, Thomas E Hutson, et al.
American Journal of Clinical Oncology|August 16, 2012
The impact of tyrosine kinase inhibitors on the multimodality treatment of brain metastases from renal cell carcinomaJonathan Verma, Eric Jonasch, Pamela K Allen, et al.
Urology|May 8, 2007
Cytoreductive nephrectomy for T4NxM1 renal cell carcinoma: the M.D. Anderson Cancer Center experienceWassim Kassouf, Ricardo Sanchez-Ortiz, Pheroze Tamboli, et al.
Melanoma Research|February 17, 2005
Melanoma of unknown primary: experience at Massachusetts General Hospital and Dana-Farber Cancer InstituteKenneth A Katz, Eric Jonasch, F Stephen Hodi, et al.
Clinical Genitourinary Cancer|September 6, 2017
Phase 2 Trial of Capecitabine, Gemcitabine, and Bevacizumab in Sarcomatoid Renal-Cell CarcinomaAbhishek Maiti, Maryam Nemati-Shafaee, Pavlos Msaouel, et al.
Palliative & Supportive Care|January 30, 2026
Sex differences in the association of emotional approach coping with stress and quality of life among patients with renal cell carcinomaChelsea G Ratcliff, Robin Semelsberger, Surena F Matin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2014
Randomized controlled trial of expressive writing for patients with renal cell carcinomaKathrin Milbury, Amy Spelman, Christopher Wood, et al.
Neuro-Oncology Advances|June 15, 2026
Explainable machine learning/artificial intelligence model for estimating postoperative survival in renal cell carcinoma brain metastasis patientsZuhair Majeed, Semiha Ozgul, Peng Li, et al.
European Urology|October 19, 2010
Primary tumor response to targeted agents in patients with metastatic renal cell carcinomaE Jason Abel, Stephen H Culp, Nizar M Tannir, et al.
Pageof 28

Showing results (71-80 of 271) with videos related to

Sort By:
Pageof 28
European Radiology|November 13, 2015
The radiogenomic risk score stratifies outcomes in a renal cell cancer phase 2 clinical trialNeema Jamshidi, Eric Jonasch, Matthew Zapala, et al.
Clinical Genitourinary Cancer|December 16, 2014
First-Line and Sequential Use of Pazopanib Followed by Mammalian Target of Rapamycin Inhibitor Therapy Among Patients With Advanced Renal Cell Carcinoma in a US Community Oncology SettingNicholas J Vogelzang, Michelle D Hackshaw, Thomas E Hutson, et al.
American Journal of Clinical Oncology|August 16, 2012
The impact of tyrosine kinase inhibitors on the multimodality treatment of brain metastases from renal cell carcinomaJonathan Verma, Eric Jonasch, Pamela K Allen, et al.
Urology|May 8, 2007
Cytoreductive nephrectomy for T4NxM1 renal cell carcinoma: the M.D. Anderson Cancer Center experienceWassim Kassouf, Ricardo Sanchez-Ortiz, Pheroze Tamboli, et al.
Melanoma Research|February 17, 2005
Melanoma of unknown primary: experience at Massachusetts General Hospital and Dana-Farber Cancer InstituteKenneth A Katz, Eric Jonasch, F Stephen Hodi, et al.
Clinical Genitourinary Cancer|September 6, 2017
Phase 2 Trial of Capecitabine, Gemcitabine, and Bevacizumab in Sarcomatoid Renal-Cell CarcinomaAbhishek Maiti, Maryam Nemati-Shafaee, Pavlos Msaouel, et al.
Palliative & Supportive Care|January 30, 2026
Sex differences in the association of emotional approach coping with stress and quality of life among patients with renal cell carcinomaChelsea G Ratcliff, Robin Semelsberger, Surena F Matin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2014
Randomized controlled trial of expressive writing for patients with renal cell carcinomaKathrin Milbury, Amy Spelman, Christopher Wood, et al.
Neuro-Oncology Advances|June 15, 2026
Explainable machine learning/artificial intelligence model for estimating postoperative survival in renal cell carcinoma brain metastasis patientsZuhair Majeed, Semiha Ozgul, Peng Li, et al.
European Urology|October 19, 2010
Primary tumor response to targeted agents in patients with metastatic renal cell carcinomaE Jason Abel, Stephen H Culp, Nizar M Tannir, et al.
Pageof 28